Page 44 - MemoriaCIBER-2017ENG

Dear colleagues at the CIBER of Cardiovascular diseases (CIBERCV); I am writing to thank you for the great e ort you have made in 2017 I feel that the balance of this rst year of our thematic area is satisfactory, based on both the achievements attained and on my perception of the enthusiasm and commitment of the whole CIBERCV, which I have also clearly noticed inside and outside our organisation
The transition from the Cardiovascular Research Network to the constitution and stabilisation of the CIBERCV ha not been a simple matter Belonging to the CIBER Consortium gives us a budgetary sta- bility that is impossible to attain by means of other nancing tools of the Instituto de Salud Carlos III This stable nancing nevertheless goes along with an extremely high degree of responsibility From both the standpoint of management and assess- ment, belonging to the most powerful biomedical research structure in this country implies an even greater degree of scrutiny by society and nanc- ing bodies It is our duty to prove that the economic e ort made by society to nance our cooperation is indeed a productive investment
Thanks to the enormous dedication of all the Groups in 2017 we have developed the Master Plan 2017-2021 of the CIBERCV This is our rst scien- ti c plan and one in which the objectives and work packages in each of the research programmes are explained This master plan is a dynamic tool that we are going to look over again every year to make sure that this adapts to the needs and scienti c capacities of our institution
In 2017 we have also set up an objective and transparent pluri-annual assessment plan, which is agreed on with the di erent agents involved, from the research groups to the management of the Instituto de Salud Carlos III The assessment process is by its own de nition a complex aspect that must be seen as a tool for identi cation of the degree of accomplishment of the objectives of this institution The thorough appraisal of this rst year has thus enabled us to identify areas of excellence (e g over 800 articles JCR, 223 of which are in rst decile journals with an accumulated impact fac- tor of around 4000 points) It is similarly important to also have identi ed areas in which we need to improve (e g transfer of results to society and ac- complishment of European projects) On this ba- sis, in 2018 we can take greater advantage of our strong points and become more competitive
Last but not least, in 2017 the conditions for the Training and Mobility Programme and of the Inter- national and Institutional Relations Programme have been drawn up Both programmes are foun- dations for the CIBERCV’s future and something which our institution has to work hard on to (1) identify and train the new generation of scientists and (2) to place this country’s cardiovascular re- search and innovation among the most relevant and competitive in the world
Scienti c Director’s Presentation
Francisco Fernández-Avilés
44 CIBER ANNUAL REPORT 2017